US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof
Patent 10093730 was granted and assigned to Genentech on October, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 19 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+102 characters)
Article
Patent abstract
The invention provides interleukin-33 (IL-33) antibodies and methods of using the same.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Dhaya Seshasayee0
Gerald R. Nakamura0
Hongkang Xi0
Jack Bevers, III0
Menno Van Lookeren Campagne0
Meredith Hazen0
Nancy Chiang0
Philip E. Hass0
Rajita Khosla0
Wenwu Zhai0
Yi-Chun Hsiao0
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100937300
Date of Patent
October 9, 2018
0Patent Application Number
149377780
Date Filed
November 10, 2015
0Patent Primary Examiner
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10093730
Date of patent
October 9, 2018
Patent application number
14937778
Date Filed
November 10, 2015
Patent primary examiner
Find more entities like US Patent 10093730 Anti-interleukin-33 antibodies and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.